We are thrilled to announce the launch of our brand new website: www.luminarygroup.co.uk Luminary Group, is an international executive search and business consultancy specializing in the Life Sciences and Pharmaceutical sectors. Contact us today! #NewWebsite #LuminaryGroup #DigitalLaunch #ExploreNow
About us
Luminary Group is a international business consultancy focused on the life sciences and pharmaceutical sectors. Headquartered at St Magnus House, 3 Lower Thames Street, Central London, EC3R 6HD, we deliver comprehensive services in three key areas. Luminary Executive: Specializing in C-suite to Director-level appointments, we identify top talent for positions including Chairman, Board members, CEO, CCO, COO, AVP to Director level. Luminary Staffing: We provide both temporary and permanent staffing solutions tailored to meet the commercial, project management, medical, biometrics, software and operational needs of our clients. Luminary Consulting: Offering high-quality services in medical writing, regulatory affairs, quality assurance, pharmacovigilance, and data science for the medical and pharmaceutical industries. We also provide strategic partnerships to accelerate growth through Recruitment Process Outsourcing (RPO) and Functional Service Provider (FSP) services. Lastly, our advisory services assist in data partnerships, leveraging our extensive network of leading RWE, RWD, and AI enterprises across the US and Europe, and provide guidance for business collaborations with biotechnology firms and navigating mergers and acquisitions. Our expertise includes Real World Evidence (RWE), eClinical solutions, Artificial Intelligence (AI), Biotechnology, Consulting, and Medical Devices. Operating globally with a presence in the USA, Europe, APAC, and the Middle East, we take pride in our exclusive talent pool, ranging from C-Suite to Managerial levels, and our partnerships with returning clients and candidates. Our collaborations extend across a diverse range of companies, from corporate giants to innovative start-ups. For more information, please visit our website: www.luminarygroup.co.uk.
- Website
-
www.luminarygroup.co.uk
External link for Luminary Group
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- City of London
- Type
- Privately Held
- Founded
- 2023
- Specialties
- Executive Search, Headhunting, Consulting, Life Sciences, Pharmacovigilence, Regulatory Affairs, CMC, Biotechnology, Diagnostics, CRO, Clinical Trials, Cell & Gene Therapy, Machine Learning, Real World Evidence, Real World Data, eClinical, eCOA, RPO, FSP, Corporate Development, Partnerships, Data Partnerships, RWE, RWD, and Artificial Intelligence
Locations
-
Primary
City of London , GB
-
4th St N, STE 300
7901
St. Petersburg, FL , 33702, US
Employees at Luminary Group
Updates
-
𝗕𝗶𝗰𝗮𝗿𝗮, 𝗭𝗲𝗻𝗮𝘀 𝗼𝘂𝘁𝗹𝗶𝗻𝗲 𝗽𝗹𝗮𝗻𝘀 𝗳𝗼𝗿 $𝟭𝟴𝟬𝗠 𝗜𝗣𝗢𝘀 𝗮𝗺𝗶𝗱 𝗿𝗲𝘀𝘁𝗼𝗿𝗲𝗱 𝗼𝗽𝘁𝗶𝗺𝗶𝘀𝗺 𝗳𝗼𝗿 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 𝗱𝗲𝗯𝘂𝘁𝘀 Bicara Therapeutics and Zenas BioPharma are now a step closer to kicking open a mini-IPO window for drug developers this fall. https://lnkd.in/dCfVgMy7
-
𝗟𝗶𝗹𝗹𝘆-𝗯𝗮𝗰𝗸𝗲𝗱 𝗢𝗿𝘀𝗼𝗕𝗶𝗼 𝗿𝗮𝗶𝘀𝗲𝘀 $𝟲𝟳𝗠 𝗳𝗼𝗿 𝘀𝗹𝗮𝘁𝗲 𝗼𝗳 𝗼𝗯𝗲𝘀𝗶𝘁𝘆 𝗱𝗿𝘂𝗴𝘀 𝗮𝘀 𝗰𝗼𝗺𝗯𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗮𝗸𝗲 𝗿𝗼𝗼𝘁 California biotech startup OrsoBio is betting the future of obesity drugs lies in combination approaches. G. Mani Subramanian https://lnkd.in/d967v6uq
Exclusive: Lilly-backed OrsoBio raises $67M for slate of obesity drugs as combinations take root
endpts.com
-
𝗖𝗕𝗘𝗥 𝗰𝗵𝗶𝗲𝗳 𝗳𝗼𝗿𝗲𝗰𝗮𝘀𝘁𝘀 𝗯𝗲𝘁𝘁𝗲𝗿 𝗴𝗹𝗼𝗯𝗮𝗹 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗰𝗼𝗻𝘃𝗲𝗿𝗴𝗲𝗻𝗰𝗲 𝗮𝗿𝗼𝘂𝗻𝗱 𝗰𝗲𝗹𝗹 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 Peter Marks, who’s responsible for the FDA oversight of cell and gene therapies, expects regulators around the world will be better at collaborating on gene … https://lnkd.in/dWqnNd2v
CBER chief forecasts better global regulatory convergence around cell and gene therapies
endpts.com
-
𝗟𝗶𝗹𝗹𝘆 𝘂𝗻𝘃𝗲𝗶𝗹𝘀 𝗺𝗼𝗿𝗲 𝗽𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗹𝗮𝘁𝗲-𝘀𝘁𝗮𝗴𝗲 𝗱𝗮𝘁𝗮 𝗳𝗼𝗿 𝗶𝘁𝘀 𝗼𝗻𝗰𝗲-𝘄𝗲𝗲𝗸𝗹𝘆 On Thursday, Eli Lilly and Company dropped more data for its once-weekly insulin candidate in adults with type 2 diabetes. In two Phase 3 trials, dubbed QWINT … https://lnkd.in/duwdV-bB
Lilly unveils more positive late-stage data for its once-weekly insulin
endpts.com
-
𝗭𝗶𝗽𝗕𝗶𝗼 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝘂𝘀𝗶𝗻𝗴 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗔𝗜 𝘁𝗼 𝗺𝗮𝗸𝗲 𝗰𝗼𝗺𝗽𝗮𝗰𝘁 𝗽𝗿𝗼𝘁𝗲𝗶𝗻𝘀 As several well-funded companies race to make generative AI models that can design new protein therapies from scratch, one small startup has …Roee Farber , ZipBio https://lnkd.in/dCptnp3g
Exclusive: ZipBio launches using generative AI to make compact proteins
endpts.com
-
𝗕𝗶𝗼𝗠𝗮𝗿𝗶𝗻 𝗿𝗲𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲𝘀 𝗳𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝘀𝘁𝗮𝗳𝗳 𝘀𝗵𝗮𝗸𝗲𝘂𝗽, 𝘀𝗹𝗼𝘄 𝗥𝗼𝗰𝘁𝗮𝘃𝗶𝗮𝗻 𝘀𝗮𝗹𝗲𝘀 BioMarin Pharmaceutical Inc. laid out a new corporate strategy on Wednesday, following months of reorganization and multiple staff reductions. The new structure relies on three key business …Alexander Hardy https://lnkd.in/dKtUHTKa
BioMarin restructures following staff shakeup, slow Roctavian sales
endpts.com
-
𝗥𝗼𝗰𝗵𝗲 𝘂𝗻𝘃𝗲𝗶𝗹𝘀 𝗺𝗼𝗿𝗲 𝗺𝗶𝗱-𝘀𝘁𝗮𝗴𝗲 𝗱𝗮𝘁𝗮 𝗳𝗼𝗿 𝗕𝗧𝗞 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿 𝗶𝗻 𝗿𝗲𝗹𝗮𝗽𝘀𝗶𝗻𝗴 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝘀𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀 Roche touted new Phase 2 data for its BTK inhibitor fenebrutinib in relapsing multiple sclerosis, noting that patients on the drug maintained low levels of … https://lnkd.in/dJwEkmis
Roche unveils more mid-stage data for BTK inhibitor in relapsing multiple sclerosis
endpts.com
-
𝗟𝗶𝗹𝗹𝘆 𝗶𝗻𝗸𝘀 𝗼𝗯𝗲𝘀𝗶𝘁𝘆 𝗱𝗲𝗮𝗹 𝘄𝗶𝘁𝗵 𝘀𝗲𝗲𝗱-𝘀𝘁𝗮𝗴𝗲 𝗥𝗡𝗔 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗮𝘀 𝗶𝘁𝘀 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗲𝗳𝗳𝗼𝗿𝘁 𝗲𝗻𝘁𝗲𝗿𝘀 𝘁𝗵𝗲 𝘀𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 Eli Lilly and Company is pairing up with a so-called “dark genome” biotech startup to hunt for a new generation of obesity and metabolic drugs. Samir Ounzain HAYA Therapeutics https://lnkd.in/dgxKy_Pk
Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight
endpts.com
-
We are excited to announce the expansion of our team with the addition of our very first US employee after 1 year and 8 months in business! Please join us in welcoming Evelyn Dougherty as our Senior Partner - USA, who will be spearheading our growth from our new office in Miami, Florida. 🇺🇸 Evelyn brings a wealth of experience as a specialist headhunter in the Life Sciences industry, focusing on connecting top talent with leading companies in niche areas such as Real World Evidence (RWE), Health Economics and Outcomes Research (HEOR), and Real World Data (RWD). With over 4 years of experience, she has developed deep expertise in these specialized sectors, covering various commercial roles like Business Developers, Product Managers, Marketing, and Customer Success professionals, particularly within HEOR and RWE companies and vendors. Evelyn has a strong track record in Executive Search and the commercial domain, successfully placing high-level roles such as Business Development Directors, Account Directors, Strategic Alliances, and Corporate Development roles. Her passion lies in connecting professionals who excel in selling RWE and HEOR solutions and services with opportunities that perfectly align with their skills and aspirations. Welcome to the team, Evelyn! 🚀